Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Todays Announcement Goblet Expansion

<< Previous

Bullboard Posts

Next >>

Comment by Angler101on May 09, 2024 1:07pm

68 Views

Post# 36031557

RE:RE:RE:RE:RE:Todays Announcement Goblet Expansion

Noteable.....Pela's answer to your question was nowhere even close to as weak as your response to my point that you falsely accuse someone of insurrection when he has never been convicted of such, or even for that matter even ever been charged......you recused to even reply, and THAT, my arrogant friend, is the very definition of weak!....especially considering the fact that you are guilty of felony tax evasion!

<< Previous

Bullboard Posts

Next >>

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta